文献速递胃肠动力与功能性疾病

瑜伽治疗肠易激综合征:随机对照试验的系统评价与Meta分析

Yoga for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Gastroenterol · 2025-05-13

该系统评价与Meta分析检索截至2024年10月的多个数据库,纳入11项随机对照试验共535例患者,评估瑜伽对肠易激综合征症状的影响。结果显示瑜伽与对照组在胃肠道症状严重程度、焦虑、抑郁及生活质量方面均无显著差异,证据不确定,作者认为在开展进一步大规模随机对照试验前不能推荐瑜伽作为肠易激综合征的治疗方法。

要点

  • 纳入11项随机对照试验共535例患者,瑜伽干预方案和疗程差异较大。
  • 瑜伽与对照组在胃肠道症状严重程度、焦虑、抑郁及生活质量上均无显著差异。
  • 作者认为证据不确定且纳入试验方法学异质性大、偏倚风险高,不能推荐瑜伽作为肠易激综合征治疗。

核心结论

  • 证据不确定,瑜伽未减轻肠易激综合征患者的胃肠道症状严重程度、焦虑和抑郁,也未改善生活质量。
  • 鉴于纳入随机对照试验存在相当大的方法学异质性和高偏倚风险,在开展进一步大规模随机对照试验填补当前证据缺口之前,不能推荐瑜伽作为肠易激综合征的治疗方法。

研究设计与样本

  • 系统评价与Meta分析,系统检索PubMed、EMBASE、WOS、SCOPUS和Cochrane数据库至2024年10月。
  • 纳入11项随机对照试验,共535例患者;其中7项纳入成人,3项纳入儿童或青少年,另1项纳入青少年和年轻成人。
  • 连续变量采用标准化均数差(SMD)合并,使用Stata MP version 17计算置信区间(CI),采用χ²检验和I²统计量评估异质性。
  • PROSPERO注册号:CRD42024611633。

主要发现

  • 瑜伽组与对照组在缓解胃肠道症状严重程度方面无差异(SMD -0.66,95%CI -1.51至0.18,P=0.12)。
  • 瑜伽组与对照组在焦虑方面无差异(SMD -0.39,95%CI -0.85至0.06,P=0.09)。
  • 瑜伽组与对照组在抑郁方面无差异(SMD -0.46,95%CI -1.15至0.22,P=0.19)。
  • 瑜伽组与对照组在改善生活质量方面无差异(SMD 0.53,95%CI -0.38至1.44,P=0.25)。
  • 瑜伽干预类型在各试验间不同,项目持续时间为6周至8个月,单次课程持续时间为40至90分钟。

临床怎么用

  • 作者认为,在开展进一步大规模随机对照试验填补当前证据缺口之前,不能推荐瑜伽作为肠易激综合征的治疗方法。

局限性

  • 证据不确定。
  • 纳入的随机对照试验存在相当大的方法学异质性。
  • 纳入的随机对照试验存在高偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Irritable bowel syndrome (IBS) affects between 10% and 20% of the global population. The therapeutic effect of yoga on IBS symptoms has been investigated by several randomized controlled trials (RCTs) with inconsistent findings. We conducted this review to synthesize the current evidence on yoga's effect on IBS symptoms. METHODS: A systematic review and meta-analysis were performed through systematically searching PubMed, EMBASE, WOS, SCOPUS, and Cochrane through October 2024. Continuous variables were pooled using the standardized mean difference (SMD), with confidence intervals (CIs) using Stata MP version 17. We assessed heterogeneity using the χ 2 test and I2 statistics. PROSPERO ID: CRD42024611633. RESULTS: Eleven RCTs with 535 patients were included. Seven RCTs included adults, 3 included pediatric or adolescent patients, and another included adolescents and young adults. The yoga intervention type varied among the included trials, with the program duration ranging from 6 weeks to 8 months and the session duration ranging from 40 to 90 minutes. There was no difference between yoga and control groups in alleviating the severity of gastrointestinal symptoms (SMD -0.66, with 95% CI -1.51 to 0.18, P = 0.12), anxiety (SMD -0.39, with 95% CI -0.85 to 0.06, P = 0.09), and depression (SMD -0.46, with 95% CI -1.15 to 0.22, P = 0.19) or improving quality of life (SMD 0.53, with 95% CI -0.38 to 1.44, P = 0.25). DISCUSSION: With uncertain evidence, yoga did not reduce the gastrointestinal severity of symptoms, anxiety, and depression or improve quality of life in patients with IBS. In light of the considerable methodological heterogeneity and the high risk of bias within the included RCTs, Yoga cannot be recommended as a treatment for IBS before conducting further large-scale RCTs to fill the current evidence gaps.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Saab O, Al-Obaidi H, Algodi M, et al. Yoga for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Gastroenterol. 2025. PMID: 40358469. doi:10.14309/ajg.0000000000003524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。